Molecular characterization of NOS3 and SOD1 genes as markers for detecting patients with breast cancer
- 1Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, 44001, Iraq.
- 2Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, 44001, Iraq. abbas.salihi@su.edu.krd.
- 3Center of Research and Strategic Studies, Lebanese French University, Erbil, Kurdistan Region, 44002, Iraq. abbas.salihi@su.edu.krd.
- 0Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, 44001, Iraq.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Genetic variations in NOS3 and SOD1 genes are linked to breast cancer (BC) development. These polymorphisms correlate with increased oxidative stress markers, suggesting a role in BC pathogenesis and potential for biomarker discovery.
Area Of Science
- Genetics and Molecular Biology
- Cancer Research
- Biochemistry
Background
- Breast cancer (BC) remains a leading cause of cancer-related mortality in women worldwide.
- Identifying novel biomarkers for early detection and prognosis is crucial for improving patient outcomes.
- This study focuses on the genetic polymorphisms of NOS3 (endothelial nitric oxide synthase) and SOD1 (superoxide dismutase 1) in relation to BC development.
Purpose Of The Study
- To investigate the association between NOS3 and SOD1 gene polymorphisms and breast cancer development.
- To explore the relationship between these genetic variations, oxidative stress markers, and tumor progression.
- To examine the functional interactions of NOS3 and SOD1 with other genes involved in redox balance.
Main Methods
- A case-control study design was employed with 30 breast cancer patients and 30 healthy controls.
- Sanger sequencing was utilized to identify mutations in NOS3 and SOD1 genes.
- Enzyme-linked immunosorbent assay (ELISA) measured oxidative stress markers (peroxynitrite and superoxide dismutase), and GENEMANIA analyzed protein-protein interactions.
Main Results
- Thirty-two polymorphisms in NOS3 and sixteen in SOD1 were identified, along with nine predicted amino acid alterations in SOD1.
- Breast cancer patients exhibited significantly higher levels of peroxynitrite (ONOO-) and superoxide dismutase (SOD) compared to controls (p < 0.0001 and p < 0.001, respectively).
- Network analysis revealed interactions among NOS3, SOD1, and oxidative stress-related genes, emphasizing their role in cellular redox homeostasis.
Conclusions
- Polymorphisms in NOS3 and SOD1 genes may contribute to breast cancer pathogenesis, evidenced by altered oxidative stress markers.
- Further validation in larger cohorts is necessary to establish NOS3 and SOD1 polymorphisms as reliable biomarkers for BC risk assessment.
- This research deepens the understanding of genetic and oxidative stress mechanisms in cancer biology, identifying potential therapeutic targets.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

